ENTA
Enanta Pharmaceuticals Inc
12.20$
-3.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 96.2% | 90.7% | 89.5% | 69.5% | 69.4% | 82.5% | 72.8% | 91.8% | 82.0% | 89.0% | 72.4% | 81.9% | 91.5% | 79.6% | 72.8% | |
| – | 26.2% | 20.2% | 7.6% | 19.8% | 8.8% | 5.9% | 20.1% | 15.4% | 10.5% | 17.8% | 13.0% | 11.6% | 18.5% | 9.9% | 11.5% | |
| – | 89.4% | 83.9% | 86.8% | 58.4% | 59.0% | 74.7% | 68.5% | 74.5% | 68.4% | 78.8% | 55.3% | 65.5% | 80.0% | 65.9% | 67.3% | |
| – | 1.0% | 5.6% | 1.4% | 2.9% | 6.4% | 4.6% | 3.2% | 16.2% | 10.5% | 4.8% | 13.8% | 12.9% | 8.6% | 10.3% | 2.5% | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | -8.5% | – | – | – | – | |
| – | 2.0% | 1.2% | 1.0% | 1.2% | 2.4% | 2.8% | 2.5% | 2.0% | 2.2% | 1.8% | 2.4% | 7.8% | – | – | – | |
| – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | 605.7% | 15.8% | 5.6% | 4.4% | 4.0% | 4.0% | 7.6% | 5.0% | 5.6% | 7.2% | 9.4% | 15.6% | 53.1% | 65.8% | 76.9% | |
| – | 8.2% | 11.0% | 3.9% | 3.1% | 2.7% | 2.8% | 6.4% | 3.9% | 4.6% | 4.9% | 8.2% | 7.8% | 13.6% | 15.3% | 17.3% | |
| – | – | – | – | 0.1% | 0.0% | 0.0% | 0.0% | – | – | 0.9% | 1.0% | 0.8% | 1.1% | 9.6% | 12.1% | |
| – | 2.2% | 3.5% | 1.3% | 1.2% | 0.6% | 1.2% | 1.1% | 1.1% | 1.4% | 1.2% | 2.2% | 1.6% | 0.9% | 2.1% | 0.7% | |
| – | – | – | 0.0% | 0.0% | 0.1% | 0.1% | 0.2% | 0.4% | 0.3% | – | – | – | – | – | – | |
| – | -505.7% | 84.2% | 94.4% | 95.6% | 96.0% | 96.0% | 92.4% | 95.0% | 94.4% | 92.8% | 90.6% | 84.4% | 46.9% | 34.2% | 23.1% | |
| – | -505.8% | -221.2% | -91.9% | -47.0% | 2.4% | 9.8% | 13.9% | 28.3% | 33.4% | 26.0% | 11.0% | -19.2% | -44.8% | -85.8% | -144.2% | |
| – | 49.1% | 17.9% | 8.4% | 12.3% | 7.8% | 6.8% | 5.9% | 5.0% | 4.3% | 4.1% | 4.6% | 5.4% | 4.5% | 5.6% | 7.6% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.